Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Post by mercedesmanon Mar 02, 2023 10:20pm
515 Views
Post# 35316646

There hmmm goes with that wonky math again.

There hmmm goes with that wonky math again.

From two of his( they, there)  most recent posts

" it'll take 7yrs to complete the Trial

and 

"Back on June 20th at the AGM Spectral had 37 patients

.... Eight months later (without Covid burden on ICUs) they have only been able to enroll13 patients"


First off it's actually 52 per the presentation

52-37 = 15 in 8 months 

= 1.875 per month ( not great at all but much higher than hmmmm has calculated )

90-52 = 38 to go until interim ( see APs post for this explanation) 

38/1.875 = 20 months IF they continue at this, agreed, VERY SLOW pace. 

 

1 year and 8 months is not 7 years ( or in other words 84 months) 

20 months is not 84 months ( it's less than a quarter of 84 per my calculator ) 

if you're going to bash at least be accurate with your numbers. 

I suspect that the BOD and Mgt is getting enough pressure from certain shareholders that they should be able to pick up the pace and reduce that 20 to maybe 14?, 12?, 10?

So in summary, per Hmmmmm,  this is dead money for 7 years. 

I say, I wouldn't  want to be short or not owning, or out altogether once the pace starts to tick up ... even by just a few more per month. 

I also suspect that restarting a trial after a pandemic is a bit like starting up a steam engine. Takes a bit of time to get moving again... but once you build up the necessary head of steam the pace of forward momentum begins to quicken with less energy expended and each shovel full of coal. 

But it's not coal this BB gang is shovelling. 

 

<< Previous
Bullboard Posts
Next >>